Yayın:
Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity

Sadeleştirilmiş öğe sayfası
dc.contributor.authorÖZTÜRK, AHMET ALPER
dc.contributor.authorNamlı, İrem
dc.contributor.authorAbdurrahman Aygül
dc.contributor.orcid0000-0001-9596-0538
dc.contributor.orcid0000-0003-4671-831X
dc.contributor.orcid0000-0003-3887-1381
dc.date.accessioned2025-11-13T09:48:26Z
dc.date.issued2021-03-17
dc.identifier.doihttps://doi.org/10.1089/adt.2020.1014
dc.identifier.endpage175
dc.identifier.issn1540-658X
dc.identifier.issue3
dc.identifier.openalexW3138793598
dc.identifier.startpage156
dc.identifier.urihttps://hdl.handle.net/11421/2252
dc.identifier.urihttps://doi.org/10.1089/adt.2020.1014
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofAssay and Drug Development Technologies
dc.rightsrestrictedAccess
dc.subjectPLGA
dc.subjectCefaclor
dc.subjectKinetics
dc.subjectChemistry
dc.subjectParticle size
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectBroth microdilution
dc.subjectAntibacterial activity
dc.subjectNuclear chemistry
dc.subjectPharmacokinetics
dc.subjectMinimum inhibitory concentration
dc.subjectAntibiotics
dc.subjectPharmacology
dc.subjectCephalosporin
dc.subjectMedicine
dc.subjectIn vitro
dc.subjectBacteria
dc.subjectBiology
dc.subjectBiochemistry
dc.subjectInternal medicine
dc.subjectInfectious disease (medical specialty)
dc.subject.sdg3
dc.titleCefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5079685563
local.authorid.openalexA5038466398

Dosyalar

Koleksiyonlar

Publications